A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of MTX-463 in Participants with Idiopathic Pulmonary Fibrosis (IPF) (MTX-463-I201)

Principal Investigator

Dr Peter Saunders

Contact us

Email: emcrf@ouh.nhs.uk

IRAS number

1012013